• Educational resources
  • Events
  • Expert Panel
  • Learning Hub
    Learning Hub
    • EoE Learning Hub
    • Chronic Spontaneous Urticaria Learning Hub
    • Type 2 Asthma Learning Hub
    • Prurigo Nodularis Learning Hub
    • Atopic Dermatitis Learning Hub
    • Rhinology Learning Hub
No matches
  • Cookie policy
  • Privacy policy
  • About us
  • Join ADVENT
  • Contact us

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: LebanonChange country/region

Educational Resources

Categories
Dermatology: 
  • Atopic dermatitis
  • Chronic pruritus of unknown origin
  • Chronic spontaneous urticaria
  • Prurigo nodularis
Gastroenterology: 
  • Eosinophilic esophagitis
Pulmonology: 
  • Asthma
Rhinology: 
  • Chronic rhinosinusitis with nasal polyps
Filters
Topic: 
  • Burden of disease
  • Pathophysiology
  • Guidelines and recommendations
  • Clinical management
  • Co-existing type 2 inflammatory diseases
Format: 
  • Expert Video
  • Podcast
  • Slide presentation
  • Infographic
  • Video animation
  • Interactivity
Length: 
  • Short (<5 minutes)
  • Medium (5-15 minutes)
  • Long (> 15 minutes)
Sort by: Newest
  • Newest
  • Oldest
  • A-Z
  • Z-A
Persistence of AD From Childhood Into Adulthood
Dermatology
3 min
expert video

Persistence of AD From Childhood Into Adulthood

Role of Type 2 Inflammation in Skin Barrier Disruption and Itch
Dermatology
4 min
expert video

Role of Type 2 Inflammation in Skin Barrier Disruption and Itch

Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD
Dermatology
3 min
expert video

Prevalence of Food Allergy and Other Atopic Comorbidities in Children With AD

Key Treatment Considerations for Management of Atopic Dermatitis in Children
Dermatology
2 min
expert video

Key Treatment Considerations for Management of Atopic Dermatitis in Children

ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis
Dermatology
20 min
Podcast

ADVENT On Air | Early Intervention and Disease Modification in Atopic Dermatitis

Epidemiology and Pathophysiology of AD in Children
Dermatology
2 min
expert video

Epidemiology and Pathophysiology of AD in Children

Identification and Management of AD Uncontrolled With Topical Therapies in Children
Dermatology
3 min
expert video

Identification and Management of AD Uncontrolled With Topical Therapies in Children

Type 2 Inflammation Within Skin Tissue in AD
Dermatology
4 min
expert video

Type 2 Inflammation Within Skin Tissue in AD

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis
Dermatology
5 min
Infographic

CCL17 (TARC): A Key Player and Biomarker in Atopic Dermatitis

IL-4 Contributes to Systemic Type 2 Inflammation in AD
Dermatology
4 min
expert video

IL-4 Contributes to Systemic Type 2 Inflammation in AD

Latest Real-World Data on Advanced Systemic Treatments for Patients With AD
Dermatology
13 min
expert video

Latest Real-World Data on Advanced Systemic Treatments for Patients With AD

The Importance of Early Intervention and the Potential for Disease Modification in Patients With AD
Dermatology
15 min
expert video

The Importance of Early Intervention and the Potential for Disease Modification in Patients With AD

    1
    ...
    678
    ...
    16